Levocetirizine dihydrochloride 0.5 MG/ML Oral Solution — RxCUI 855168
RxNorm drug concept · Semantic clinical drug
RxCUI 855168
Semantic clinical drug · SCD
● Current RxNorm concept 9 FDA products
11 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI855168
Official nameLevocetirizine dihydrochloride 0.5 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslevocetirizine dihydrochloride 2.5 MG per 5 ML Oral Solution; levocetirizine dihydrochloride 2.5 MG in 5 mL Oral Solution
FDA products mapped9
Package NDCs mapped11
Reported Medicaid activity (SDUD)71,359 prescriptions · 38 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Levocetirizine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's an antihistamine used to relieve the classic allergy symptoms — runny nose, sneezing, itchy and watery eyes, and itching of the nose or throat — caused by seasonal hay fever o...
- What exactly is levocetirizine used for?
- It can, yes — drowsiness is the most commonly reported side effect and it's more likely at higher doses. Many people tolerate it fine, but until you know how it affects you, it's s...
- Yes, you can take it with or without food — either way works. If you take it with a high-fat meal, it may take a little longer to kick in and the peak level in your blood may be sl...
🕸️ Concept Web — How Levocetirizine dihydrochloride 0.5 MG/ML Oral So... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Levocetirizine dihydrochloride 0.5 MG/ML Oral Solution
RxCUI 855168 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Levocetirizine
356887IN -
Levocetirizine dihydrochloride
402349PIN
-
Levocetirizine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Xyzal
398335BN
-
Xyzal
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Levocetirizine Oral Solution
759919SCDF -
Levocetirizine dihydrochloride Oral Solution
2647466SCDFP -
Levocetirizine Oral Liquid Product
1163204SCDG -
Levocetirizine Oral Product
1163205SCDG -
Levocetirizine dihydrochloride Oral Liquid Product
2661627SCDGP -
Levocetirizine dihydrochloride Oral Product
2662910SCDGP -
Levocetirizine Oral Solution [Xyzal]
759922SBDF -
Levocetirizine dihydrochloride Oral Solution [Xyzal]
2658185SBDFP - +5 more in this family
-
Levocetirizine Oral Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Levocetirizine dihydrochloride 0.5 MG/ML
855167SCDC -
Levocetirizine dihydrochloride 0.5 MG/ML Oral Solution [Xyzal]
855170SBD -
Levocetirizine dihydrochloride 0.5 MG/ML [Xyzal]
855169SBDC
-
Levocetirizine dihydrochloride 0.5 MG/ML
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Levocetirizine dihydrochloride 0.5 MG/ML
SCDC · 855167 -
Levocetirizine Oral Solution
SCDF · 759919 -
Levocetirizine dihydrochloride Oral Solution
SCDFP · 2647466 -
Levocetirizine Oral Liquid Product
SCDG · 1163204 -
Levocetirizine Oral Product
SCDG · 1163205 -
Levocetirizine dihydrochloride Oral Liquid Product
SCDGP · 2661627 -
Levocetirizine dihydrochloride Oral Product
SCDGP · 2662910
Brand-Name Concepts
-
Levocetirizine dihydrochloride 0.5 MG/ML Oral Solution [Xyzal]
SBD · 855170 -
Levocetirizine dihydrochloride 0.5 MG/ML [Xyzal]
SBDC · 855169 -
Levocetirizine Oral Solution [Xyzal]
SBDF · 759922 -
Levocetirizine dihydrochloride Oral Solution [Xyzal]
SBDFP · 2658185 -
Xyzal Oral Liquid Product
SBDG · 1186636 -
Xyzal Oral Product
SBDG · 1186637 -
Xyzal
BN · 398335
📦 FDA Products & Package NDCs
9 products · 11 package NDCs
11 package NDCs map to RxCUI 855168 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 31722-0659-31 | 1 BOTTLE in 1 CARTON (31722-659-31) / 148 mL in 1 BOTTLE | levocetirizine dihydrochloride | Camber Pharmaceuticals, Inc. | 2019-04-01 |
| 41167-3533-00 | 1 BOTTLE in 1 CARTON (41167-3533-0) / 148 mL in 1 BOTTLE | Childrens Xyzal Allergy | Chattem, Inc. | 2024-01-04 |
| 41167-3533-01 | 1 BOTTLE in 1 CARTON (41167-3533-1) / 295 mL in 1 BOTTLE | Childrens Xyzal Allergy | Chattem, Inc. | 2026-01-01 |
| 41167-3535-00 | 1 BOTTLE in 1 CARTON (41167-3535-0) / 148 mL in 1 BOTTLE | Childrens Xyzal Allergy | Chattem, Inc. | 2023-02-01 |
| 41167-3535-01 | 1 BOTTLE in 1 CARTON (41167-3535-1) / 296 mL in 1 BOTTLE | Childrens Xyzal Allergy | Chattem, Inc. | 2023-04-01 |
| 41167-5803-09 | 90 TABLET, FILM COATED in 1 BOTTLE (41167-5803-9) | Xyzal | Chattem, Inc. | 2017-07-24 |
| 41167-5804-05 | 1 BOTTLE in 1 CARTON (41167-5804-5) / 148 mL in 1 BOTTLE | Xyzal | Chattem, Inc. | 2017-07-24 |
| 45802-0680-28 | 148 mL in 1 BOTTLE (45802-680-28) | levocetirizine dihydrochloride | Padagis Israel Pharmaceuticals Ltd | 2011-11-07 |
| 62135-0917-38 | 148 mL in 1 BOTTLE (62135-917-38) | Levocetirizine Dihydrochloride | Chartwell RX, LLC | 2022-08-30 |
| 63629-2533-01 | 1 BOTTLE in 1 CARTON (63629-2533-1) / 148 mL in 1 BOTTLE | levocetirizine dihydrochloride | Bryant Ranch Prepack | 2011-11-07 |
| 72162-1424-02 | 148 mL in 1 BOTTLE (72162-1424-2) | levocetirizine dihydrochloride | Bryant Ranch Prepack | 2023-09-26 |
Observed labelers:
Chattem, Inc. (6) ·
Bryant Ranch Prepack (2) ·
Camber Pharmaceuticals, Inc. (1) ·
Chartwell RX, LLC (1) ·
Padagis Israel Pharmaceuticals Ltd (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.